EXTRARENAL COMPLICATIONS OF THE NEPHROTIC SYNDROME

被引:60
作者
HARRIS, RC
ISMAIL, N
机构
[1] Department of Medicine, Division of Nephrology, Vanderbilt University School of Medicine, Nashville, Tennessee
关键词
NEPHROTIC SYNDROME; HYPOALBUMINEMIA; HYPERLIPIDEMIA; EDEMA; ACUTE RENAL FAILURE; HYPERCOAGULABILITY; RENAL VEIN THROMBOSIS; CALCIUM; VITAMIN D;
D O I
10.1016/S0272-6386(12)80369-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The systemic complications of nephrotic syndrome are responsible for much of the morbidity and mortality seen with this condition. This review discusses the causes for the hypoalbuminemia and the associated metabolic abnormalities of the nephrotic syndrome. No unifying hypothesis exists for the induction, maintenance, and resolution of nephrotic edema. In view of the wide spectrum of renal diseases leading to the nephrotic syndrome, more than a single mechanism may be responsible for the renal salt retention in these diverse conditions. Although hypoalbuminemia may be important, especially when plasma oncotic pressure is very low (serum albumin <1.5 to 2.0 g/dL), primary impairment of salt and water excretion by the nephrotic kidney appears to be a major factor in pathogenesis of the edema. However, the decreased serum albumin and/or oncotic pressure seen with nephrotic syndrome is a major contributing factor to the development of the hyperlipidemia of nephrotic syndrome. Patients with unremitting nephrotic syndrome should be considered for combined dietary and lipid-lowering drug therapy. Urinary losses of binding proteins lead to the observed abnormalities in the endocrine system and in trace metals, and urinary losses of coagulation factors contribute to the hypercoagulable state. At present, selective renal venography is recommended when the suspicion of renal vein thrombosis is justified by clinical presentation. The impact on renal function caused by treating asymptomatic chronic renal vein thrombosis is undetermined, but anticoagulation for chronic renal vein thrombosis is associated with relatively few complications. © 1994, National Kidney Foundation. All rights reserved. All rights reserved.
引用
收藏
页码:477 / 497
页数:21
相关论文
共 147 条
[1]   EFFECTS OF DEXTRAN, POLYVINYLPYRROLIDONE AND GAMMA GLOBULIN ON HYPERLIPIDEMIA OF EXPERIMENTAL NEPHROSIS [J].
ALLEN, JC ;
BAXTER, JH ;
GOODMAN, HC .
JOURNAL OF CLINICAL INVESTIGATION, 1961, 40 (03) :499-&
[2]   CALCIUM AND VITAMIN-D HOMEOSTASIS IN THE NEPHROTIC SYNDROME - CURRENT STATUS [J].
ALON, U ;
CHAN, JCM .
NEPHRON, 1984, 36 (01) :1-4
[3]   HYPER-COAGULABILITY IN THE NEPHROTIC SYNDROME [J].
ANDRASSY, K ;
RITZ, E ;
BOMMER, J .
KLINISCHE WOCHENSCHRIFT, 1980, 58 (19) :1029-1036
[4]  
[Anonymous], 1978, KIDNEY INT, V13, P159
[5]   LIPID ABNORMALITIES IN RENAL-DISEASE [J].
APPEL, G ;
SCHAEFER, E ;
MADIAS, NE ;
MADAIO, MP ;
HARRINGTON, JT ;
LEVEY, AS ;
NARAYAN, G ;
MEYER, K .
KIDNEY INTERNATIONAL, 1991, 39 (01) :169-183
[6]  
Appel G B, 1989, Am J Med, V87, p45N
[7]   THE HYPERLIPIDEMIA OF THE NEPHROTIC SYNDROME - RELATION TO PLASMA-ALBUMIN CONCENTRATION, ONCOTIC PRESSURE, AND VISCOSITY [J].
APPEL, GB ;
BLUM, CB ;
CHIEN, S ;
KUNIS, CL ;
APPEL, AS .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (24) :1544-1548
[8]   PATHOGENESIS OF HYPERLIPIDEMIA IN THE NEPHROTIC SYNDROME [J].
ATTMAN, PO ;
ALAUPOVIC, P .
AMERICAN JOURNAL OF NEPHROLOGY, 1990, 10 :69-75
[9]   DECREASED FREE 1,25-DIHYDROXYCHOLECALCIFEROL INDEX IN PATIENTS WITH THE NEPHROTIC SYNDROME [J].
AUWERX, J ;
DEKEYSER, L ;
BOUILLON, R ;
DEMOOR, P .
NEPHRON, 1986, 42 (03) :231-235
[10]  
BARRAGRY JM, 1977, LANCET, V2, P629